Find clinical trials for hidradenitis suppurativa. Search for hidradenitis suppurativa clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 45
Active & Responsive
Pelashield™ PainGuard™ vs Restrata® in HS Surgery
for
Hidradenitis Suppurativa (HS)
Location: Newark NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT07316192
Recruiting
Active & Responsive
Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%
for
Hidradenitis Suppurativa (HS)
Location: Norfolk VA
Sponsor: Virginia Clinical Research, Inc.
Sex: All
Age: 18+
Code: NCT06645821
Early_phase1, Recruiting
Active & Responsive
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 18+
Code: NCT06058520
Early_phase1, Recruiting
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
for
Hidradenitis Suppurativa
Location: St. John's, New York NY, Hoboken NJ, Richmond Hill,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06799000
Phase3, Recruiting
Clinical and Biological Characteristics of Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 13+
Code: NCT03967600
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
for
Hidradenitis Suppurativa, Healthy Volunteers
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 22 - 70
Code: NCT05066113
Recruiting
Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
Botulinum Toxin Therapy in Hidradenitis Suppurativa
for
Hidradenitis Suppurativa, Hyperhidrosis
Location: Worcester MA
Sponsor: University of Massachusetts, Worcester
Sex: All
Age: 18 - 70+
Code: NCT05403710
Recruiting
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab